Works matching DE "ANDROGEN deprivation therapy"
Results: 837
Contemporary prostate cancer radiation therapy trials may underestimate the risk of biochemical recurrence.
- Published in:
- Journal of Sexual Medicine, 2025, v. 22, n. 2, p. 369, doi. 10.1093/jsxmed/qdae191
- By:
- Publication type:
- Article
Determining Prostate Cancer-Related Pathways and the Role of the RPH3AL Gene.
- Published in:
- Experimed, 2024, v. 14, n. 3, p. 215, doi. 10.26650/experimed.1505817
- By:
- Publication type:
- Article
Plastic orchiectomy and some indicators of improvement of vital parameters and general condition of the organism in blood of the men with prostate cancer.
- Published in:
- Indian Journal of Biochemistry & Biophysics, 2024, v. 61, n. 1, p. 39, doi. 10.56042/ijbb.v60i12.5683
- By:
- Publication type:
- Article
Efficacy of androgen receptor signaling inhibitors in combination with androgen deprivation therapy for castration-sensitive metastatic prostate cancer: a retrospective analysis in a Japanese cohort.
- Published in:
- International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 351, doi. 10.1007/s10147-024-02670-5
- By:
- Publication type:
- Article
Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1496646
- By:
- Publication type:
- Article
Osteonecrosis of Jaws in Prostate Cancer Patients Treated With Antiresorptive Drugs: A Review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00504-6
- By:
- Publication type:
- Article
CPCC晚期前列腺癌中国专家共识——转移性 激素敏感性前列腺癌起始应用新型内分泌治疗 的全程管理（2022年版).
- Published in:
- China Oncology, 2022, v. 32, n. 12, p. 1242, doi. 10.19401/j.cnki.1007-3639.2022.12.013
- By:
- Publication type:
- Article
mpMRI联合<sup>99m</sup>Tc-PSMA SPECT/CT检测前列腺癌 新辅助雄激素剥夺治疗后显著残留病灶的价值 研究
- Published in:
- China Oncology, 2022, v. 32, n. 2, p. 134, doi. 10.19401/j.cnki.1007-3639.2022.02.005
- By:
- Publication type:
- Article
Analysis of factors related to osteoporotic vertebral fracture in prostate cancer patients.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-00886-5
- By:
- Publication type:
- Article
Analysis of factors related to osteoporotic vertebral fracture in prostate cancer patients.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-00886-5
- By:
- Publication type:
- Article
Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-00876-7
- By:
- Publication type:
- Article
Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer.
- Published in:
- Tomography: A Journal for Imaging Research, 2022, v. 8, n. 3, p. 1477, doi. 10.3390/tomography8030120
- By:
- Publication type:
- Article
Assessment of Aortoiliac Atherosclerotic Plaque on CT in Prostate Cancer Patients Undergoing Treatment.
- Published in:
- Tomography: A Journal for Imaging Research, 2022, v. 8, n. 2, p. 607, doi. 10.3390/tomography8020050
- By:
- Publication type:
- Article
A COMPARATIVE ANALYSIS OF SERUM ALKALINE PHOSPHATASE LEVELS IN ADT RESPONSIVE AND ADT NON-RESPONSIVE PROSTATE CANCER PATIENTS.
- Published in:
- Journal of Experimental Zoology India, 2024, v. 27, n. 1, p. 877, doi. 10.51470/jez.2024.27.1.877
- By:
- Publication type:
- Article
[18F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 2, p. 277, doi. 10.1007/s11307-020-01546-0
- By:
- Publication type:
- Article
Clinical and pathological prognostic factors for prostate cancer progression to a castration resistant disease.
- Published in:
- Onkologia i Radioterapia, 2024, v. 18, n. 2, p. 1
- By:
- Publication type:
- Article
Testosterone castration levels in patients with prostate cancer: Is there a difference between GnRH agonist and GnRH antagonist? Primary results of an open-label randomized control study.
- Published in:
- Investigative & Clinical Urology, 2023, v. 64, n. 6, p. 572, doi. 10.4111/icu.20230027
- By:
- Publication type:
- Article
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2022.2163242
- By:
- Publication type:
- Article
In the Absence of Testosterone: Hormonal Treatment, Masculinity, and Health among Prostate Cancer Patients Engaging in an Exercise Programme.
- Published in:
- Social Sciences (2076-0760), 2023, v. 12, n. 7, p. 417, doi. 10.3390/socsci12070417
- By:
- Publication type:
- Article
Comparative pathology of dog and human prostate cancer.
- Published in:
- Veterinary Medicine & Science, 2022, v. 8, n. 1, p. 110, doi. 10.1002/vms3.642
- By:
- Publication type:
- Article
Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-51389-w
- By:
- Publication type:
- Article
Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-51389-w
- By:
- Publication type:
- Article
Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42711-z
- By:
- Publication type:
- Article
Statin use and outcomes of oncological treatment for castration-resistant prostate cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45958-8
- By:
- Publication type:
- Article
Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42711-z
- By:
- Publication type:
- Article
Switching mechanism from AR to EGFR signaling via 3-O-sulfated heparan sulfate in castration-resistant prostate cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38746-x
- By:
- Publication type:
- Article
Discovery of a small-molecule NDR1 agonist for prostate cancer therapy.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1367358
- By:
- Publication type:
- Article
Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1284899
- By:
- Publication type:
- Article
YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1244655
- By:
- Publication type:
- Article
Androgen deprivation therapy plus abiraterone or docetaxel as neoadjuvant therapy for very-high-risk prostate cancer: a pooled analysis of two phase II trials.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1217303
- By:
- Publication type:
- Article
Activation of the HNRNPA2B1/miR-93-5p/FRMD6 axis facilitates prostate cancer progression in an m6A-dependent manner.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 7, p. 1242, doi. 10.7150/jca.83863
- By:
- Publication type:
- Article
Palliative TURP Combined with Intermittent ADT Is A Curative Therapy to Some Elderly Men with Localized Prostate Adenocarcinoma.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 7, p. 1232, doi. 10.7150/jca.83825
- By:
- Publication type:
- Article
Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36253-1
- By:
- Publication type:
- Article
Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 01, doi. 10.3389/fendo.2022.1055826
- By:
- Publication type:
- Article
The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.926585
- By:
- Publication type:
- Article
New Insights and Emerging Therapeutic Approaches in Prostate Cancer.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.840787
- By:
- Publication type:
- Article
Concomitant Bilateral Inferior Gluteal Lymph Node Involvement in Metastatic Prostate Adenocarcinoma Detected on <sup>68</sup> Gallium-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
The Association between Insomnia and Orgasmic Difficulty for Prostate Cancer Patients - Implication to Sex Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0256778
- By:
- Publication type:
- Article
Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0248461
- By:
- Publication type:
- Article
Nomograms for Metastasis-Free and Overall Survival for Pathologically Node Positive Prostate Cancer Patients Treated With or Without Radiation Therapy Plus Short-Term ADT.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 3, p. e263, doi. 10.1016/j.clgc.2022.01.018
- By:
- Publication type:
- Article
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 123, doi. 10.1016/j.clgc.2021.11.012
- By:
- Publication type:
- Article
Targeting the PI3K-AKT-mTOR Pathway in Castration Resistant Prostate Cancer: A Review Article.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. e1, doi. 10.1016/j.clgc.2021.07.014
- By:
- Publication type:
- Article
Efficacy and Adverse Events of Docetaxel for Metastatic, Hormone-sensitive Prostate Cancer Among Elderly Men: A Post Hoc Analysis of the CHAARTED Trial.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 5, p. 388, doi. 10.1016/j.clgc.2021.03.016
- By:
- Publication type:
- Article
Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 3, p. 217, doi. 10.1016/j.clgc.2020.07.012
- By:
- Publication type:
- Article
Treating De Novo Metastatic Castration-Sensitive Prostate Cancer With Visceral Metastases: An Evolving Issue.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 1, p. 83, doi. 10.1016/j.clgc.2020.06.001
- By:
- Publication type:
- Article
POJAVNOST NESANIRANIH ZUBA KOD BOLESNIKA KOJI ŽIVE U RURALNOM PODRUČJU, A BOLUJU OD METASTATSKOG KASTRACIJSKI REZISTENTNOG RAKA PROSTATE, U ODNOSU NA ONE KOJI ŽIVE U URBANOM SREDIŠTU – ISKUSTVO JEDNOG CENTRA.
- Published in:
- Lijecnicki Vjesnik, 2024, v. 146, p. 43, doi. 10.26800/LV-146-supl4-2
- By:
- Publication type:
- Article
LIJEČENJE LOKALNOG VISOKORIZIČNOG KARCINOMA PROSTATE.
- Published in:
- Lijecnicki Vjesnik, 2024, v. 146, p. 18, doi. 10.26800/LV-146-supl4-1
- By:
- Publication type:
- Article
CR78 Virchow’s node as the first manifestation of disseminated prostatic cancer.
- Published in:
- Lijecnicki Vjesnik, 2023, v. 145, p. 85, doi. 10.26800/LV-145-supl2-CR78
- By:
- Publication type:
- Article